TY - JOUR
T1 - A multicentre analysis of Nocardia pneumonia in Spain
T2 - 2010–2016
AU - Ercibengoa, Maria
AU - Càmara, Jordi
AU - Tubau, Fe
AU - García-Somoza, Dolores
AU - Galar, Alicia
AU - Martín-Rabadán, Pablo
AU - Marin, Mercedes
AU - Mateu, Lourdes
AU - García-Olivé, Ignasi
AU - Prat, Cristina
AU - Cilloniz, Catia
AU - Torres, Antonio
AU - Pedro-Botet, Maria Luisa
AU - Ardanuy, Carmen
AU - Muñoz, Patricia
AU - Marimón, Jose María
N1 - Publisher Copyright:
© 2019 The Author(s)
PY - 2020/1
Y1 - 2020/1
N2 - Objective: To analyse all cases of Nocardia pneumonia occurring between 2010 and 2016 in five Spanish hospitals. Methods: This was a retrospective observational analysis of clinical and microbiological data collected from 55 cases of Nocardia pneumonia. Results: There were one to 20 cases per hospital and six to nine cases per year. Chronic obstructive pulmonary disease, bronchiectasis, and asthma were the main predisposing underlying respiratory conditions. Thirty-four patients were receiving systemic and/or inhaled corticosteroids prior to infection, eight had neoplasia, and six had haematological malignancies. Clinical and radiological findings were common to pneumonia of other infectious aetiologies, except for the frequent presence of nodules and cavitation. Overall, the 1-year mortality was high (38.2%), and mortality was directly related to the pulmonary disease in 15 patients (27.3%). The most frequently identified species were N. cyriacigeorgica (n = 21), N. abscessus (n = 8), and N. farcinica (n = 5). All Nocardia isolates were susceptible to linezolid and all but two were susceptible to amikacin and trimethoprim–sulfamethoxazole. Conclusions: Nocardia pneumonia-associated mortality remains high, probably because of the debilitated status of patients in whom this pathogen is able to cause pulmonary infection.
AB - Objective: To analyse all cases of Nocardia pneumonia occurring between 2010 and 2016 in five Spanish hospitals. Methods: This was a retrospective observational analysis of clinical and microbiological data collected from 55 cases of Nocardia pneumonia. Results: There were one to 20 cases per hospital and six to nine cases per year. Chronic obstructive pulmonary disease, bronchiectasis, and asthma were the main predisposing underlying respiratory conditions. Thirty-four patients were receiving systemic and/or inhaled corticosteroids prior to infection, eight had neoplasia, and six had haematological malignancies. Clinical and radiological findings were common to pneumonia of other infectious aetiologies, except for the frequent presence of nodules and cavitation. Overall, the 1-year mortality was high (38.2%), and mortality was directly related to the pulmonary disease in 15 patients (27.3%). The most frequently identified species were N. cyriacigeorgica (n = 21), N. abscessus (n = 8), and N. farcinica (n = 5). All Nocardia isolates were susceptible to linezolid and all but two were susceptible to amikacin and trimethoprim–sulfamethoxazole. Conclusions: Nocardia pneumonia-associated mortality remains high, probably because of the debilitated status of patients in whom this pathogen is able to cause pulmonary infection.
KW - Multicentre study
KW - Nocardia
KW - Nocardia cyriacigeorgica
KW - Pneumonia
KW - Respiratory infection
KW - Spain
UR - http://www.scopus.com/inward/record.url?scp=85075265271&partnerID=8YFLogxK
U2 - 10.1016/j.ijid.2019.10.032
DO - 10.1016/j.ijid.2019.10.032
M3 - Original Article
C2 - 31693939
AN - SCOPUS:85075265271
SN - 1201-9712
VL - 90
SP - 161
EP - 166
JO - International Journal of Infectious Diseases
JF - International Journal of Infectious Diseases
ER -